Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 672094, 7 pages
http://dx.doi.org/10.1155/2014/672094
Review Article

124Iodine: A Longer-Life Positron Emitter Isotope—New Opportunities in Molecular Imaging

1Nuclear Medicine, University of Catanzaro “Magna Graecia”, Viale Europa, Localita Germaneto, 88100 Catanzaro, Italy
2Nuclear Medicine, University of Bari “Aldo Moro”, Piazza Giulio Cesare, No. 11, 70124 Bari, Italy

Received 28 December 2013; Accepted 18 April 2014; Published 8 May 2014

Academic Editor: Gianluca Valentini

Copyright © 2014 Giuseppe Lucio Cascini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. B. Zanzonico, R. E. Bigler, G. Sgouros, and A. Strauss, “Quantitative SPECT in radiation dosimetry,” Seminars in Nuclear Medicine, vol. 19, no. 1, pp. 47–61, 1989. View at Google Scholar · View at Scopus
  2. S. R. Thomas, H. R. Maxon, and J. G. Kereiakes, “Techniques for quantitation of in vivo radioactivity,” in Effective Use of Computers in Nuclear Medicine, M. J. Gelfand and S. R. Thomas, Eds., pp. 468–484, McGraw-Hill, New York, NY, USA, 1988. View at Google Scholar
  3. L. P. Clarke, F. Qadir, W. Al Sheikh, G. Sfakianakis, and A. N. Serafini, “Comparison of the physical characteristics of I-131 and I-123, with respect to differentiating the relative activity in the kidneys,” Journal of Nuclear Medicine, vol. 24, no. 8, pp. 683–688, 1983. View at Google Scholar · View at Scopus
  4. P. Scalliet and A. Wambersie, “Which RBE for iodine 125 in clinical applications?” Radiotherapy and Oncology, vol. 9, no. 3, pp. 221–230, 1987. View at Google Scholar · View at Scopus
  5. K. A. Kurdziel, G. Ravizzini, B. Y. Croft, J. L. Tatum, P. L. Choyke, and H. Kobayashi, “The evolving role of nuclear molecular imaging in cancer,” Expert Opinion on Medical Diagnostics, vol. 2, no. 7, pp. 829–842, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. R. K. Grewal, M. Lubberink, K. S. Pentlow, and S. M. Larson, “The role of Iodine-124-positron emission tomography imaging in the management of patients with thyroid cancer,” PET Clinics, vol. 2, no. 3, pp. 313–320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. M. Eschmann, G. Reischl, K. Bilger et al., “Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET,” European Journal of Nuclear Medicine, vol. 29, no. 6, pp. 760–767, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. S. Pentlow, M. C. Graham, R. M. Lambrecht et al., “Quantitative imaging of iodine-124 with PET,” Journal of Nuclear Medicine, vol. 37, no. 9, pp. 1557–1562, 1996. View at Google Scholar · View at Scopus
  9. R. M. Lambrecht, M. Sajjad, M. A. Qureshi, and S. J. Al-Yanbawi, “Production of iodine-124,” Journal of Radioanalytical and Nuclear Chemistry, vol. 127, no. 2, pp. 143–150, 1988. View at Google Scholar · View at Scopus
  10. J. Schmitz, “The production of [124I]iodine and [86Y]yttrium,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 38, no. 1, supplement, pp. S4–S9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Scholten, S. Takács, Z. Kovács, F. Tárkányi, and S. M. Qaim, “Excitation functions of deuteron induced reactions on 123Te: relevance to the production of 123I and 124I at low and medium sized cyclotrons,” Applied Radiation and Isotopes, vol. 48, no. 2, pp. 267–271, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. K. F. Hassan, S. M. Qaim, Z. A. Saleh, and H. H. Coenen, “Alpha-particle induced reactions on natsb and 121sb with particular reference to the production of the medically interesting radionuclide 124i,” Applied Radiation and Isotopes, vol. 64, no. 1, pp. 101–109, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. A. Nye, M. A. Avila-Rodriguez, and R. J. Nickles, “A new binary compound for the production of 124I via the 124Te(p,n)124I reaction,” Applied Radiation and Isotopes, vol. 65, no. 4, pp. 407–412, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Qaim, A. Hohn, T. Bastian et al., “Some optimisation studies relevant to the production of high-purity 124I and 120gI at a small-sized cyclotron,” Applied Radiation and Isotopes, vol. 58, no. 1, pp. 69–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Van den Bosch, J. J. M. De Goeij, and J. A. Van der Heide, “A new approach to target chemistry for the iodine 123 production via the 124Te(p,2n) reaction,” International Journal of Applied Radiation and Isotopes, vol. 28, no. 3, pp. 255–261, 1977. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Guhlke, A. M. Verbruggen, and S. Vallabhajosula, “Radiochemistry and radiopharmacy,” in Clinical Nuclear Medicine, H. J. Biersack and L. M. Freeman, Eds., pp. 34–76, Springer, Berlin, Germany, 2007. View at Google Scholar
  17. U. Ficola, N. Quartuccio, R. Paratore, G. Treglia, A. Piccardo, and A. Cistaro, “Utility of 124I-MIBG PET/CT in the follow-up of patients with advanced neuroblastoma: first report of the AIMN PET-Pediatric Study InterGroup,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, pp. S204–S205, 2013. View at Google Scholar
  18. V. Hartung-Knemeyer, S. Rosenbaum-Krumme, C. Buchbender et al., “Malignant pheochromocytoma imaging with [124I]mIBG PET/MR,” The Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 11, pp. 3833–3834, 2012. View at Google Scholar
  19. C.-L. Lee, H. Wahnishe, G. A. Sayre et al., “Radiation dose estimation using preclinical imaging with 124I-metaiodobenzylguanidine (MIBG) PET,” Medical Physics, vol. 37, no. 9, pp. 4861–4867, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. 124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study,” http://www.clinicaltrials.gov/.
  21. M. A. Moroz, I. Serganova, P. Zanzonico et al., “Imaging hNET reporter gene expression with 124I-MIBG,” Journal of Nuclear Medicine, vol. 48, no. 5, pp. 827–836, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Reischl, D. S. Dorow, C. Cullinane et al., “Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA—first small animal PET results,” Journal of Pharmacy & Pharmaceutical Sciences, vol. 10, no. 2, pp. 203–211, 2007. View at Google Scholar · View at Scopus
  23. A. Stahlschmidt, H.-J. Machulla, G. Reischl, E. E. Knaus, and L. I. Wiebe, “Radioiodination of 1-(2-deoxy-β-d-ribofuranosyl)-2,4-difluoro-5-iodobenzene (dRFIB), a putative thymidine mimic nucleoside for cell proliferation studies,” Applied Radiation and Isotopes, vol. 66, no. 9, pp. 1221–1228, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. I. Guenther, L. Wyer, E. J. Knust, R. D. Finn, J. Koziorowski, and R. Weinreich, “Radiosynthesis and quality assurance of 5-[124I]Iodo-2′-deoxyuridine for functional PET imaging of cell proliferation,” Nuclear Medicine and Biology, vol. 25, no. 4, pp. 359–365, 1998. View at Publisher · View at Google Scholar · View at Scopus
  25. W. K. Sang, H. P. Jeong, D. Y. Seung, G. H. Min, W. C. Chang, and H. Y. Kook, “Synthesis and in vitro/vivo evaluation of iodine-123/124 labelled hypericin derivatives,” Bulletin of the Korean Chemical Society, vol. 29, no. 10, pp. 2023–2025, 2008. View at Google Scholar · View at Scopus
  26. R. G. Blasberg and J. G. Tjuvajev, “Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy,” Quarterly Journal of Nuclear Medicine, vol. 43, no. 2, pp. 163–169, 1999. View at Google Scholar · View at Scopus
  27. J. G. Tjuvajev, R. Finn, K. Watanabe et al., “Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy,” Cancer Research, vol. 56, no. 18, pp. 4087–4095, 1996. View at Google Scholar · View at Scopus
  28. L. Koehler, F. Graf, R. Bergmann, J. Steinbach, J. Pietzsch, and F. Wuest, “Radiosynthesis and radiopharmacological evaluation of cyclin-dependent kinase 4 (Cdk4) inhibitors,” European Journal of Medicinal Chemistry, vol. 45, no. 2, pp. 727–737, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. P. J. Kothari, R. D. Finn, and S. M. Larson, “Syntheses of colchicine and isocolchicine labelled with carbon-11 or carbon-13,” Journal of Labelled Compounds and Radiopharmaceuticals, vol. 36, no. 6, pp. 521–528, 1995. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Iozzo, S. Osman, M. Glaser et al., “In vivo imaging of insulin receptors by PET: preclinical evaluation of iodine-125 and iodine-124 labelled human insulin,” Nuclear Medicine and Biology, vol. 29, no. 1, pp. 73–82, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. R. M. Lambrecht, N. Woodhouse, R. Phillips et al., “Investigational study of iodine-124 with a positron camara,” American Journal of Physiologic Imaging, vol. 3, no. 4, pp. 197–200, 1988. View at Google Scholar · View at Scopus
  32. L. S. Freudenberg, G. Antoch, W. Jentzen et al., “Value of 124I-PET/CT in staging of patients with differentiated thyroid cancer,” European Radiology, vol. 14, no. 11, pp. 2092–2098, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. H. T. T. Phan, P. L. Jager, A. M. J. Paans et al., “The diagnostic value of 124I-PET in patients with differentiated thyroid cancer,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 35, no. 5, pp. 958–965, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. H. R. Maxon, “Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer,” Quarterly Journal of Nuclear Medicine, vol. 43, no. 4, pp. 313–323, 1999. View at Google Scholar · View at Scopus
  35. R. Dorn, J. Kopp, H. Vogt, P. Heidenreich, R. G. Carroll, and S. A. Gulec, “Dosimetry-guided radioactive iodine treatment in patients with metastatic differentiated thyroid cancer: largest safe dose using a risk-adapted approach,” Journal of Nuclear Medicine, vol. 44, no. 3, pp. 451–456, 2003. View at Google Scholar · View at Scopus
  36. G. L. Cascini, A. Ciarmiello, A. Labate, S. Tamburrini, and A. Quattrone, “Unexpected detection of melanoma brain metastasis by PET with iodine-124 βCIT,” Clinical Nuclear Medicine, vol. 34, no. 10, pp. 698–699, 2009. View at Publisher · View at Google Scholar · View at Scopus